Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Identification and quantification of alternative polyadenylation sites in single cell RNA-seq data using scPAISO.

Created on 07 Aug 2026

Authors

Yongjie Liu, Peiwen Xiong, Songyang Li, Xinjia Liu, Tao Liu, Qinglan Yang, Shuting Wu, Hongyan Peng, Yana Li, Lingling Zhang, Yafei Deng, Yong Zhu, Junping Wang, Youcai Deng

Published in

Journal of genetics and genomics = Yi chuan xue bao. Aug 06, 2026. Epub Aug 06, 2026.

Abstract

Alternative polyadenylation (APA) generates transcript diversity by producing mRNA isoforms with distinct 3' untranslated regions (3' UTRs) or coding sequences. Existing single-cell RNA sequencing (scRNA-seq) methods for APA analysis primarily rely on Read2 data, which lacks precise cleavage site (CS) information and limits accurate polyadenylation site (PAS) identification. Here, we present single-cell PolyAdenylation ISOform quantification (scPAISO), a computational pipeline that leverages the often-discarded Read1 from 3' tag-based scRNA-seq to enable de novo PAS identification and PAS isoform quantification. Unlike existing approaches, scPAISO directly captures mRNA 3' end cleavage sites, resulting in stronger AAUAAA motif enrichment, sharper PAS peaks, and improved spatial resolution for resolving closely spaced PASs. Across multiple datasets and biological systems, scPAISO robustly identified PASs and quantified APA dynamics, revealing stage-specific 3' UTR lengthening during hematopoietic differentiation, widespread 3' UTR remodeling in systemic sclerosis, and tissue-specific polyadenylation preferences associated with distinct RNA-binding protein programs in mice. scPAISO provides an accurate and scalable framework for single-cell APA analysis, enabling high-resolution characterization of post-transcriptional regulation and transcriptome diversity in development, physiology, and disease.

PMID:
42562343
Bibliographic data and abstract were imported from PubMed on 07 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement